Skip to content

Effects of Transcranial Magnetic Stimulation to the Cerebellum on Cognition

fMRI and TMS Analysis of Cerebellar Cognitive Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00740701
Enrollment
17
Registered
2008-08-25
Start date
2000-04-30
Completion date
2005-01-31
Last updated
2018-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Performance

Keywords

TMS, fMRI, verbal working memory, classical conditioning, eyeblink, classical eyeblink conditioning, Healthy subjects, Memory

Brief summary

Functional neuroimaging studies have shown that the cerebellum is active during cognitive performance. The investigators hypothesize that stimulation of the cerebellum with transcranial magnetic stimulation will produce brief changes in performance of the task, suggesting that cerebellar activation is necessary for normal cognitive function.

Interventions

DEVICECerebellar transcranial magnetic stimulation

single pulse TMS or repetitive TMS at 1 Hz frequency

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
National Institute on Aging (NIA)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* 19-30 years of age * Informed consent

Exclusion criteria

* History of seizure or a family history of epilepsy * History of stroke * Presence of metal anywhere in the head except the mouth * Presence of cardiac pacemakers * Presence of cochlear implants * Presence of implanted medication pump * History of heart disease * Presence of intracardiac lines * Increased intracranial pressure, such as after infarctions or trauma * Children, or outside of age range * Pregnancy * Currently taking tricyclic anti-depressants or neuroleptic medication * History of head trauma * History of respiratory disease

Design outcomes

Primary

MeasureTime frame
Behavioral performance (accuracy, or rate of conditioned responses)during computerized task performance (2 hours)

Secondary

MeasureTime frame
Reaction timeduring performance of computerized task (2 hours)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026